The Summit on Breakthrough Therapies for Addiction: Full Schedule

7:45am EDT

Breakfast & Registration

Wednesday May 15, 2024 7:45am - 8:55am EDT

Non-Accredited Session

8:55am EDT

Introductions

Speakers

Ben Greenzweig

Summit Producer, Co-Founder, CEO, Momentum Events

Wednesday May 15, 2024 8:55am - 9:00am EDT

Non-Accredited Session

9:00am EDT

Welcoming Remarks

Speakers

Alon Z. Weizer, MD, MS

Senior Vice President/Chief Medical Officer Mount Sinai Medical Center, Clinical Professor of Urology, Mount Sinai Division of Columbia University Department of Urology

Alon Weizer graduated from Duke University in 1995 with a BA in History and completed Medical School at Baylor College of Medicine in Houston, TX graduating AOA. He completed his Urology residency at Duke University Medical Center followed by a 2-year fellowship in Urologic Oncology... Read More →

Wednesday May 15, 2024 9:00am - 9:10am EDT

Non-Accredited Session

9:10am EDT

Chair’s Opening Remarks

Speakers

Owen Muir, MD

Interventional Brain Medicine, NIH Research, The Frontier Psychiatrists

Owen Scott Muir, MD Is a dual board-certified child, adolescent and adult psychiatrist, and co-author of Adolescent Suicide and Self-Injury: Mentalizing Theory and Treatment. He has held academic appointments at Hofstra-Northwell, NYU and Baylor College of Medicine. He is the... Read More →

Wednesday May 15, 2024 9:10am - 9:15am EDT

Non-Accredited Session

9:15am EDT

Beginning of CME Content

Wednesday May 15, 2024 9:15am - 9:15am EDT

Accredited CME Session

9:15am EDT

Opening Keynote Panel: The Current State of Breakthrough Therapies for Addiction

This session will examine emerging medicines and treatments that show promise in addressing substance use disorders, behavioral addictions, and co-occurring mental health conditions. We will analyze the current evidence, patient populations being studied, challenges still ahead, and the potential of these breakthroughs to transform outcomes if brought to market. Attendees will gain insight into the therapies farthest along in development and how they may expand available options for treating addiction in the years ahead.

*This session qualifies for CME.

Speakers

Jose Cruz, MD

Chairman, Department of Behavioral Medicine, Schottenstein Family Chair for Behavioral Health, Mount Sinai Medical Center

Caroline Elistin, DNP, MSN-Ed, AAPRN, FNP-BC, PMHNP-BC

Adjunct Professor, Doctorate of Nursing Practice, University of Miami

Dr. Caroline Saint-Fleur Elistin, DNP, MSN-Ed, APRN, FNP-BC, PMHNP-BC, MBA is an award winning, board certified Family & Psychiatric Mental Health Nurse Practitioner. She earned her undergraduate degree (BSN) from the University of Miami, her Master of Science degrees in Nursing Education... Read More →

Richard Seely, MD

Secretary, Florida Society of Addiction Medicine

Wednesday May 15, 2024 9:15am - 10:15am EDT

Accredited CME Session

10:15am EDT

Unraveling The Relationship Between Pain and Addiction

Clinical trials for addictions and chronic pain often exclude participants with overlapping conditions, leaving a critical gap in understanding the interplay between pain and addiction. This session delves into the underappreciated connection between these two prevalent issues. By addressing the profound relationship between pain and addiction, we can develop more comprehensive strategies for assisting individuals in their recovery journey. Failing to address the root pain, whether emotional or physical, that initially led individuals to seek drugs can hinder the effectiveness of addiction treatment.

*This session qualifies for CME.

Speakers

Michelle Weiner, DO, MPH

Director of Integrative Pain Solutions, NeuroPain Health

Dr. Michelle Weiner is Double board-certified in Interventional Pain Medicine, Physical Medicine, and Rehabilitation. She is Director of Integrative Pain management. She is a Clinical Assistant Professor at Nova Southeastern University College of Osteopathic Medicine. Dr. Weiner is... Read More →

Wednesday May 15, 2024 10:15am - 11:00am EDT

Accredited CME Session

11:00am EDT

End of CME Content

Wednesday May 15, 2024 11:00am - 11:00am EDT

Accredited CME Session

11:00am EDT

Morning Break

Wednesday May 15, 2024 11:00am - 11:30am EDT

Break & Networking

11:30am EDT

Semaglutide: A Peptide Provides Hope

Semaglutide has been approved as a weight loss treatment for nearly a decade. This peptide shows promising effects for substance and behavioral addictions too. This session will review emerging evidence and therapeutic potential of this GLP-1 receptor agonist.

Speakers

Warren K. Bickel, Ph.D.

Virginia Tech Carilion Behavioral Health Research Professor, Director, Addiction Recovery Research Center, Director, Center for Health Behaviors Research, Fralin Biomedical Research Institute at Virginia Tech Carilion

Dr. Bickel is an accomplished scholar and researcher in addiction and health behavior research. He received his Ph.D. in developmental and child psychology from the University of Kansas and completed post-doctoral training at Johns Hopkins University School of Medicine. He has led... Read More →

Wednesday May 15, 2024 11:30am - 11:45am EDT

Non-Accredited Session

12:00pm EDT

First Look at Real-World Evidence: Preliminary Results from OSU's Ibogaine Treatment Registry

The Center for Psychedelic Drug Research and Education at The Ohio State University has embarked on an ambitious project to collect data from individuals worldwide who have undergone ibogaine treatment for addiction. In this session, Dr. Stacey Armstrong will offer a first look at preliminary findings from the project’s initial phase, which started in October 2023.

Speakers

Stacey Armstrong, PhD

Senior Researcher, Center for Psychedelic Drug Research and Education (CPDRE), The Ohio State University

Dr. Stacey B. Armstrong is a senior researcher and psychologist at the Center for Psychedelic Drug Research and Education (CPDRE) at The Ohio State University College of Social Work. She earned her Ph.D. at Bowling Green State University after completing a clinical internship at the... Read More →

Wednesday May 15, 2024 12:00pm - 12:45pm EDT

Non-Accredited Session

12:45pm EDT

Lunch

Wednesday May 15, 2024 12:45pm - 2:00pm EDT

Break & Networking

2:00pm EDT

Beginning of CME Content

Wednesday May 15, 2024 2:00pm - 2:00pm EDT

2:00pm EDT

Efficacy of Ketamine in the Treatment of Substance Use Disorders

Ketamine has shown preliminary promise as a rapid-acting antidepressant. Now, a growing body of research is exploring ketamine's potential in treating addiction as well. In this session, leading experts will review mounting evidence surrounding ketamine-assisted therapy for substance use disorders. They will discuss proposed mechanisms of action, results from clinical trials, ideal patient profiles, implementation considerations, and next steps in evaluating ketamine's efficacy as an addiction treatment.

*This session qualifies for CME.

Speakers

Jennifer L. Jones, MD

Assistant Professor, Medical University of South Carolina

Elias Dakwar, MD

Associate Professor of Clinical Psychiatry, Columbia University School of Medicine

Elias Dakwar has been researching novel treatments for addictions for over a decade, with the support of several grants from the National Institutes of Health. A special focus of his research has been evaluating sub-anesthetic ketamine infusions for cocaine use disorders in both laboratory... Read More →

Wednesday May 15, 2024 2:00pm - 2:45pm EDT

Accredited CME Session

2:45pm EDT

Psilocybin: A Promising Approach to Addiction Treatment

Psilocybin has demonstrated significant potential in recent clinical trials as an adjunct to psychotherapy for addiction. This session will showcase the research and evidence surrounding psilocybin for addiction treatment.

*This session qualifies for CME.

Speakers

Peter Hendricks, PhD

Professor and Clinical Psychologist, University of Alabama at Birmingham

Peter Hendricks, PhD, is a Professor in the Department of Psychiatry and Behavioral Neurobiology, School of Medicine, at the University of Alabama at Birmingham (UAB). A clinical psychologist by training, Dr. Hendricks earned his bachelor’s degree from the University of Virginia... Read More →

Wednesday May 15, 2024 2:45pm - 3:30pm EDT

Accredited CME Session

3:30pm EDT

Exploring the Future of Breakthrough Therapies for Addiction: Research, Applications, and Scalability

This discussion will explore the evolving landscape of breakthrough addiction therapies. Throughout this session, we'll delve into recent advancements and future prospects in addiction treatment. Our discussion will highlight the latest developments in pharmaceuticals and digital interventions, demonstrating their potential to revolutionize addiction care. Thought leaders will share insights on advancing research, refining practical implementations, and amplifying the impact of transformative approaches.

*This session qualifies for CME.

Moderators

Owen Muir, MD

Interventional Brain Medicine, NIH Research, The Frontier Psychiatrists

Speakers

Lantie Jorandby, MD

Distinguished Fellow American Psychiatric Association. Chief Medical Officer, Lakeview Health

Dr. Lantie Jorandby, Chief Medical Officer at Lakeview Health in Jacksonville, FL, has dedicated her professional life to treating patients for mental illness and addiction. A nationally-recognized expert in the field and is triple board certified in general psychiatry, addiction... Read More →

Peter Hendricks, PhD

Professor and Clinical Psychologist, University of Alabama at Birmingham

Charlie Panfil

Public Policy Advisor, The Daschle Group

Charlie Panfil is a Public Policy Advisor with The Daschle Group, A Public Policy Advisory of Baker Donelson. He works with The Daschle Group’s corporate and nonprofit clients on public health & biodefense, technology, cannabis, psychedelic medicine, veterans’ mental health, and... Read More →

Wednesday May 15, 2024 3:30pm - 4:15pm EDT

Accredited CME Session

4:15pm EDT

End of CME Content

Wednesday May 15, 2024 4:15pm - 4:15pm EDT

Accredited CME Session

4:15pm EDT

Afternoon Break

Wednesday May 15, 2024 4:15pm - 4:45pm EDT

Break & Networking

4:45pm EDT

Navigating MDMA Approval: Preparing Treatment Centers for Integration into Addiction Treatment and Mental Health Practices

Join us in this session as we explore the hopefully imminent potential approval of MDMA for therapeutic use and its integration into addiction treatment plans and various mental health applications. We'll delve into how treatment centers can proactively prepare for the incorporation of this medicine, considering its promising role in mental health. What does the current observational research reveal about the effective utilization of MDMA in treatment? Gain insights into strategies for readiness, learnings from observational research, and considerations for optimizing its impact in addiction treatment and broader mental health contexts.

Speakers

Jeeshan Chowdhury, MD, DPhil

Founder & CEO, Journey Colab

Jeeshan Chowdhury, MD, DPhil, is the CEO and Co-Founder of Journey Colab, a psychedelic biotech company on a mission to transform addiction treatment. He studied at Oxford University as a Rhodes Scholar and has founded multiple healthcare startups, including Listrunner (a Y Combinator-backed... Read More →

Wednesday May 15, 2024 4:45pm - 5:30pm EDT

Non-Accredited Session

5:30pm EDT

Closing Spotlight Session: Ibogaine and Noribogaine: Mechanisms and Therapeutic Potential for Addiction

Ibogaine has shown promise as a treatment for substance use disorders, yet its mechanisms and clinical development have been constrained by safety concerns. In this session, Dr. Deborah Mash will discuss her extensive research investigating ibogaine's metabolite noribogaine, which offers a longer-acting psychoactive profile without cardiovascular toxicity. She will explain noribogaine’s unique mechanisms of action in reducing drug cravings, blocking withdrawal symptoms, and modulating stress pathways implicated in addiction. Attendees will gain key insights into ibogaine derivatives as a safer, more therapeutically powerful option for addiction treatment.

Speakers

Deborah Mash, PhD

CEO and Founder DemeRX, Professor Emeritus, University of Miami

Miami-based Deborah Mash is one of the world’s foremost experts on the hallucinogenic drug Ibogaine. She is nationally recognized as a leading researcher in the fields of addiction neurobiology, genomics, and psychedelic medicine, playing a pivotal role in over 300 published studies... Read More →

Wednesday May 15, 2024 5:30pm - 6:15pm EDT

Non-Accredited Session

6:15pm EDT

Closing Remarks

Speakers

Ben Greenzweig

Summit Producer, Co-Founder, CEO, Momentum Events

Owen Muir, MD

Interventional Brain Medicine, NIH Research, The Frontier Psychiatrists

Wednesday May 15, 2024 6:15pm - 6:30pm EDT

Non-Accredited Session

6:30pm EDT

Networking Reception: Mocktails

Wednesday May 15, 2024 6:30pm - 7:30pm EDT

Non-Accredited Session

8:00am EDT

Breakfast & Registration

Thursday May 16, 2024 8:00am - 9:00am EDT

Non-Accredited Session

9:00am EDT

Day Two Chair’s Remarks

Speakers

Deborah Mash, PhD

CEO and Founder DemeRX, Professor Emeritus, University of Miami

Thursday May 16, 2024 9:00am - 9:05am EDT

Non-Accredited Session

9:05am EDT

Interventional Brain Medicine and Neuromodulation for Addiction

The session will explore cutting-edge approaches in treating addiction through innovative techniques targeting the brain's neural circuitry. This session delves into the intersection of interventional brain medicine, which encompasses minimally invasive procedures for neurological disorders, and neuromodulation, involving the precise modulation of neural activity. Speakers present research findings and clinical applications of these methodologies, highlighting their potential in addressing addiction by targeting specific brain regions and neural pathways. Discussions focus on the efficacy, safety, and ethical considerations of utilizing these interventions to combat substance use disorders, offering insights into the evolving landscape of addiction treatment.

Speakers

Michael Sprintz, DO, DFASAM

Expert on the Intersection of Chronic Pain and Addiction

Dr. Sprintz is a national expert on the intersection of chronic pain, addiction, and digital health technologies. He received his training at institutions including Johns Hopkins, and MD Anderson Cancer Center and is triple board-certified in Pain Medicine, Addiction Medicine, and... Read More →

Owen Muir, MD

Interventional Brain Medicine, NIH Research, The Frontier Psychiatrists

Colleen A. Hanlon, PhD

Vice President, Medical & Clinical Affairs, Director, Innovation Team, BrainsWay Deep TMS

Dr. Hanlon is an internationally recognized thought-leader in the development and expansion of non-invasive neuromodulation therapeutics for addiction and has had a career that brought her from basic science research through FDA-pivotal clinical trials. Now the Vice President of... Read More →

Thursday May 16, 2024 9:05am - 10:00am EDT

Non-Accredited Session

10:00am EDT

Revolutionizing Addiction Treatment with Technology: Exploring Telehealth, EMDR Therapy, and Virtual Reality Innovations

Join us for an enlightening session as we delve into the cutting-edge realm of telehealth technologies, Eye Movement Desensitization and Reprocessing (EMDR) therapy, and Virtual Reality (VR) in our exploration of novel approaches to tackling substance use disorder. Discover the latest updates and insights into how these advancements are expanding access and transforming the landscape of addiction treatment.

Speakers

Nick Mercadante, JD

Founder and CEO, PursueCare

Nick Mercadante is CEO of PursueCare (https://www.pursuecare.com), a technology-enabled addiction treatment and behavioral health services provider. PursueCare leverages a ground-breaking virtual care platform to deliver comprehensive treatment for substance use disorder and other mental health conditions through any mobile device. PursueCare p... Read More →

Dr. Elizabeth Woodruff, LCSW, QS, EMDR

Licensed Clinical Social Work & Therapist

Dr. Elizabeth Woodruff, a distinguished Licensed Clinical Social Worker, embarked on her academic journey at Palm Beach Atlantic University, where she earned her Bachelor of Science in Psychology. Her passion for understanding the human psyche and aiding those in need propelled her... Read More →

Shel Mann

CEO and Co-Founder, FireflyVR

Thursday May 16, 2024 10:00am - 10:45am EDT

Non-Accredited Session

10:45am EDT

Morning Break

Thursday May 16, 2024 10:45am - 11:00am EDT

Break & Networking

11:15am EDT

Novel Non-Hallucinogenic Compounds for Addiction Treatment

Psychedelics have demonstrated their capacity for healing through large, shifting experiences. But what about those who are not equipped to have altered states? Join us for a conversation with Jackie von Salm of Psilera, a University of South Florida Incubator Company (USF Connect), as they provide valuable insights into how next-generation psychedelic-inspired medications can retain therapeutic effects while removing psychedelic properties.

Speakers

Jackie von Salm, PhD

Chief Science Officer, Psilera, a University of South Florida Incubator Company (USF Connect)

Dr. von Salm is a scientist with over a decade of experience in drug discovery and innovation. During her time in academia, she researched exotic marine wildlife in Antarctica and searched for new chemistry and natural medicines in the Caribbean. In 2017, she was named a most read... Read More →

Thursday May 16, 2024 11:15am - 12:00pm EDT

Non-Accredited Session

12:00pm EDT

Lunch Break

Thursday May 16, 2024 12:00pm - 1:00pm EDT

Break & Networking

1:00pm EDT

Investment Landscape for Breakthrough Therapies for Addiction

This session will analyze the current investment landscape and how stakeholders can collaborate to bring disruptive new therapies to patients struggling with addiction. Our experts will examine the challenges and opportunities associated with developing new medications and therapeutic practices to effectively treat addiction.

Moderators

Ani Chahal Honan

Founder & Managing Partner, Yunity & Imagine Fund

Ani Chahal Honan is the Founder and Managing Partner of Yunity, a highly scalable capital, startup labs, and advisory ecosystem, creating a new generation of mindful business aligned to a triple bottom line: People, Planet, and Profit. She serves as general partner for Yunity’s... Read More →

Speakers

Henry Elkus

Founder & CEO, Helena

Henry Elkus is Founder and CEO of Helena. He cares immensely about creating systems that can be leveraged to enact global, scalable, and systemic change. Henry dropped out of Yale in his second year to lead Helena full time.Helena is a global problem solving organization. Its purpose... Read More →

Simeon Schnapper

Managing Partner, JLS Fund

Thursday May 16, 2024 1:00pm - 1:45pm EDT

Non-Accredited Session

1:45pm EDT

Revolutionizing Addiction Recovery: Beond Ibogaine's Self-Motivated Workshop Approach - An Interview with Tom Feegel, Co-Founder, Beond

Explore the transformative evolution of reshaping the mental health client care model, navigating from the initial screening to uninterrupted aftercare. The focus is on nurturing an environment that places premium importance on achieving superior performance and the best possible outcomes, benefiting both patients and professionals. This session will delve into strategies to reintroduce dignity into care processes and foster successful outcomes while enhancing staff involvement in patient recovery, regardless of the approach used. Moreover, gain insights into the significance of rigorous research and meticulous result tracking, essential for the ongoing refinement and enhancement of these pioneering care methodologies.

Interviewed by: Ben Greenzweig, Summit Producer, Co-Founder, CEO, Momentum Events

Speakers

Ben Greenzweig

Summit Producer, Co-Founder, CEO, Momentum Events

Tom Feegel

Co-Founder, Beond

Tom Feegel, is a career entrepreneur and co-founder of Beond Ibogaine, a premium ibogaine-assisted treatment and research facility in Mexico that serves clients suffering from trauma & PTSD, addiction, and those striving for improved health and optimization. Beond Ibogaine is equal... Read More →

Thursday May 16, 2024 1:45pm - 2:30pm EDT

Non-Accredited Session

2:30pm EDT

Afternoon Break

Thursday May 16, 2024 2:30pm - 3:00pm EDT

Break & Networking

3:00pm EDT

Building Integration Models to Support Lasting Recovery

Sustaining recovery from addiction requires ongoing support beyond initial breakthrough therapies. Thoughtful integration is critical to empower individuals with tools and communities with resources for maintaining transformative changes. This session will explore protocols, sets, and settings to promote post-treatment wellbeing.

Moderators

Orlando Andrews

Community Engagement Manager, Crossroads

Speakers

Allison Feduccia, PhD

Psychedelic Scientist, Co-founder of Psychedelic Support, Co-Founder, Scientific Advisor, Project New Day

Allison Feduccia, PhD, is a neuropharmacologist, psychedelic researcher, and educator. She is the Co-Founder + CEO of Psychedelic Support, a platform for education and connection to psychedelic practitioners, and a scientific advisor for Project New Day and the Etheridge Found... Read More →

Danielle Nova

Founder, Psychedelic Recovery and Executive Director, San Francisco Psychedelic Society

Danielle Nova, the Founder of Psychedelic Recovery and Executive Director of the San Francisco Psychedelic Society, is a leading advocate, educator, public speaker and guide in the transformative power of psychedelics for addiction recovery. With over six years of professional experience... Read More →

Thursday May 16, 2024 3:00pm - 3:45pm EDT

Non-Accredited Session

3:45pm EDT

Closing Panel: The Role of Spirituality in Addiction Treatment and Recovery

Many find solace in seeking out spirituality, faith, and ritual to support their recovery journey. Many rely on it as a source of strength and renewal. This session will explore ways to holistically integrate spiritual practices into addiction treatment plans. The speaker will discuss perspectives on how psychedelic medicine can catalyze spiritual awakenings for those overcoming substance abuse disorders.

Speakers

John J. Giordano PhD, Doctor Of Humane Letters, CCJS, MAC, CAP

Co-Owner, JC's Recovery Center Advisory Board Member, Legacy Medical Blue Zone Miami Founder, The National Institute For Holistic Addiction Studies (NIFHAS)

Dr. John Giordano is an expert in the treatment of addiction, mental health, and the founder of The National Institute For Holistic Addiction Studies (NIFHAS). He has been included in 80 medical and scientific peer review journals and is the author of “Proven Holistic Treatment... Read More →

Timothy McMahan King

Senior Fellow, Clergy for a New Drug Policy

Timothy McMahan King is a writer, Senior Fellow for Clergy for a New Drug Policy, and the owner of Vagabond Strategies. He is the former chief strategy officer for Sojourners and has served as a consultant for national non-profits, advocacy campaigns, and political candidates. The... Read More →

Thursday May 16, 2024 3:45pm - 4:30pm EDT

Non-Accredited Session

4:30pm EDT

Closing Remarks & Conference Conclusion

Speakers

Non-Accredited Session